Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)

Status Completed

Clinical Trial Summary

Candida is the most common fungal pathogen identified in hospitalized patients. This study will seek to enroll adult patients (18 years of age or older) with invasive Candida infections (involving deep tissues and organs). The study will not enroll patients whose only site of Candida infection was the bloodstream. Patients that fulfill all study entry criteria will receive a single daily dose of caspofungin. Caspofungin, an intravenous echinocandin antifungal agent, is already approved for the treatment of invasive candidiasis. The dosage strength and duration of caspofungin will be individualized for each patient based on disease, severity of disease and extent of infection.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Candidiasis

Clinical Trial Details

NCT number	NCT00083343
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 2
Start date	May 2004
Completion date	February 2006

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01982071` - A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia	Phase 4
Completed	`NCT02391532` - Effect of Probiotic Bacteria on Oral Candida in Frail Elderly	N/A
Completed	`NCT01447407` - Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine	Phase 1
Not yet recruiting	`NCT00889356` - Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis	Phase 3
Completed	`NCT00105144` - Study of Micafungin in Patients With Invasive Candidiasis or Candidemia	Phase 3
Completed	`NCT00163111` - A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.	Phase 3
Completed	`NCT00138502` - Funguria in Hospitalized Patients
Not yet recruiting	`NCT04502277` - Bioavailability of Flucanazole	Early Phase 1
Completed	`NCT03203551` - Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous.	N/A
Completed	`NCT05044156` - Investigation of the Relationship Between Salivary Histatine-5 Level and Vaginal Candidiasis in Women
Completed	`NCT01322698` - Staging Candidiasis in ICU Patients	N/A
Terminated	`NCT01092832` - A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients	Phase 3
Terminated	`NCT00095316` - Caspofungin Study for Fungal Infections in Adults in Critical Care Settings	Phase 3
Completed	`NCT04122560` - Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration	Phase 4
Completed	`NCT02641717` - Validity of Patient-Collected Wet Mounts	N/A
Recruiting	`NCT01253954` - A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China	N/A
Completed	`NCT00734539` - Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight	Phase 3
Completed	`NCT00797420` - Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers	Phase 1
Completed	`NCT00001937` - Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients	Phase 3
Completed	`NCT02666716` - Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients